Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05429502
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2022-06-17
Brief Title:
Study of Efficacy and Safety of Ribociclib LEE011 in Combination With Topotecan and Temozolomide TOTEM in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-29
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-17
First Submit QC Date:
June 17 2022
Study First Post Date:
2022-06-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-09
Last Update Post Date:
2024-05-13
Last Update Post Date Type:
ACTUAL